This study is no longer recruiting.
This study was a clinical trial which tested an experimental drug for the treatment of Post-Traumatic Stress Disorder (PTSD).
The population recruited were individuals who have served in the Iraq or Afghanistan wars and were experiencing any difficulties related to a mild or moderate traumatic brain injury (TBI) sustained during deployment.
Following the initial screening phase, participants received the medication treatment for 8 weeks and the placebo for 8 weeks. This study lasted a total of 18 weeks. Participants were assessed at baseline and then every 2 weeks until the end of the study. Participants were compensated for all completed assessments (up to a total of $400).
Manhattan Offices
425 East 61st Street
New York, NY 10065
435 East 70th Street
New York, NY 10021
Westchester Office
21 Bloomingdale Road
White Plains, NY 10605
